NL6614961A - - Google Patents

Info

Publication number
NL6614961A
NL6614961A NL6614961A NL6614961A NL6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A NL 6614961 A NL6614961 A NL 6614961A
Authority
NL
Netherlands
Application number
NL6614961A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6614961A publication Critical patent/NL6614961A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6614961A 1965-10-22 1966-10-21 NL6614961A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1751468A CH499528A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer Pyrimidine
CH506568A CH478819A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506468A CH478818A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506368A CH478817A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1463065A CH478816A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1133066 1966-08-05

Publications (1)

Publication Number Publication Date
NL6614961A true NL6614961A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-04-24

Family

ID=27543760

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6614961A NL6614961A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1965-10-22 1966-10-21

Country Status (11)

Country Link
US (1) US3503963A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE688660A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6683919D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (5) CH499528A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1670392A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (3) FR1500479A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1135259A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL26473A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6614961A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE345273B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU436494A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders
US12156866B2 (en) 2018-06-06 2024-12-03 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH486471A (de) * 1966-07-28 1970-02-28 Ciba Geigy Verfahren zur Herstellung neuer Aminopyrimidine
CA2515963A1 (en) * 2003-02-24 2004-09-10 Arena Pharmaceuticals, Inc. Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
CN101870690A (zh) * 2004-06-04 2010-10-27 艾尼纳制药公司 作为代谢调节剂的经取代芳基和杂芳基衍生物及其相关病症的预防和治疗
HN2005000795A (es) * 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
EA013084B1 (ru) * 2005-09-16 2010-02-26 Арена Фармасьютикалз, Инк. Модуляторы метаболизма и лечение связанных с ним нарушений
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
CN103221391B (zh) 2010-01-27 2018-07-06 艾尼纳制药公司 (R)-2-(7-(4-环戊基-3-(三氟甲基)苄基氧基)-1,2,3,4-四氢环戊二烯并[b]吲哚-3-基)乙酸及其盐的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1959-09-25 1900-01-01

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8933083B2 (en) 2003-01-14 2015-01-13 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7838525B2 (en) 2003-07-11 2010-11-23 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US8546429B2 (en) 2003-07-11 2013-10-01 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US12156866B2 (en) 2018-06-06 2024-12-03 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor

Also Published As

Publication number Publication date
CH478819A (de) 1969-09-30
US3503963A (en) 1970-03-31
SE345273B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-05-23
SU436494A3 (ru) 1974-07-15
FR1500479A (fr) 1967-11-03
CH478818A (de) 1969-09-30
FR6083M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-06-04
BE688660A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-04-21
BR6683919D0 (pt) 1973-12-04
SU427513A3 (ru) 1974-05-05
CH499528A (de) 1970-11-30
CH478816A (de) 1969-09-30
GB1135259A (en) 1968-12-04
FR6084M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-06-04
CH478817A (de) 1969-09-30
IL26473A (en) 1971-08-25
DE1670392A1 (de) 1970-07-16

Similar Documents

Publication Publication Date Title
JPS4310222Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU6521265A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE669403A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE671805A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE661304A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE663735A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE664336A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE664337A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE664770A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE665432A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE665442A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE669882A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE669486A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE665590A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE666221A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE666305A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE666429A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE667145A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE667537A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE667866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE668155A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE668544A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE668937A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE669284A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE659312A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)